BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹310 Cr | ₹258 Cr | ₹240 Cr | ₹176 Cr | ₹100 Cr |
What is the latest Total Liabilities ratio of BALAXI PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹310 Cr |
| Mar2024 | ₹258 Cr |
| Mar2023 | ₹240 Cr |
| Mar2022 | ₹176 Cr |
| Mar2021 | ₹100 Cr |
How is Total Liabilities of BALAXI PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹310 Cr | 20.13 | |
| Mar2024 | ₹258 Cr | 7.79 | |
| Mar2023 | ₹240 Cr | 35.81 | |
| Mar2022 | ₹176 Cr | 77.04 | |
| Mar2021 | ₹100 Cr | - | |
Compare Total Liabilities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹110.7 Cr | 10.7% | -12.3% | -66.7% | Stock Analytics | |
| ADANI ENTERPRISES | ₹258,297.0 Cr | -3.7% | -10.3% | -3.9% | Stock Analytics | |
| REDINGTON | ₹20,240.1 Cr | 3.8% | -3.6% | 2% | Stock Analytics | |
| HONASA CONSUMER | ₹9,409.7 Cr | -0.2% | 1.4% | 31.9% | Stock Analytics | |
| MMTC | ₹8,392.5 Cr | -0.2% | -12.6% | 8.8% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹7,529.0 Cr | 6.7% | -17.7% | 23.4% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 10.7% |
-12.3% |
-66.7% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses